HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Yang Selected Research

elcatonin

2/2013Comparison of parathyroid hormone (1-34) and elcatonin in postmenopausal women with osteoporosis: an 18-month randomized, multicenter controlled trial in China.
8/2010[A randomized, multicenter, active-controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with that of elcatonin in postmenopausal women with osteoporosis in China].
12/2009A randomized, multicenter controlled trial to compare the efficacy of recombinant human parathyroid hormone (1-34) with elcatonin in postmenopausal women with osteoporosis in China.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Yang Research Topics

Disease

381Neoplasms (Cancer)
11/2022 - 07/2002
126Inflammation (Inflammations)
08/2022 - 03/2006
112Infections
06/2022 - 01/2000
69Pain (Aches)
01/2022 - 10/2002
66Fibrosis (Cirrhosis)
01/2022 - 01/2006
59Neoplasm Metastasis (Metastasis)
05/2022 - 09/2004
55Prostatic Neoplasms (Prostate Cancer)
07/2022 - 08/2002
52Hypertension (High Blood Pressure)
11/2022 - 08/2002
45Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 08/2002
43Myocardial Infarction
01/2022 - 11/2005
42Wounds and Injuries (Trauma)
07/2022 - 02/2002
40Hypoxia (Hypoxemia)
01/2022 - 01/2002
38Ischemia
01/2022 - 04/2002
38Reperfusion Injury
01/2022 - 12/2004
36Breast Neoplasms (Breast Cancer)
07/2022 - 01/2006
35Carcinogenesis
10/2022 - 10/2003
34Hepatocellular Carcinoma (Hepatoma)
01/2022 - 07/2003
32Carcinoma (Carcinomatosis)
06/2022 - 07/2002
31Myocardial Ischemia (Ischemic Heart Diseases)
01/2022 - 09/2005
29Lung Neoplasms (Lung Cancer)
05/2022 - 02/2005
28Stroke (Strokes)
08/2022 - 09/2002
26Infarction (Infarctions)
04/2022 - 04/2002
26Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 07/2005
25Body Weight (Weight, Body)
01/2021 - 07/2005
24Heart Failure
01/2022 - 01/2006
24Type 2 Diabetes Mellitus (MODY)
01/2022 - 12/2004
23Hemorrhage
01/2022 - 12/2002
22Obesity
02/2022 - 12/2004
21Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2022 - 10/2004
20Stomach Neoplasms (Stomach Cancer)
12/2021 - 05/2003
19Hyperaldosteronism (Conn Syndrome)
11/2022 - 01/2018
19Pulmonary Arterial Hypertension
04/2022 - 05/2008
18Alzheimer Disease (Alzheimer's Disease)
09/2022 - 06/2008
18Insulin Resistance
01/2022 - 10/2006
17Sepsis (Septicemia)
08/2022 - 01/2003
17Brain Ischemia (Cerebral Ischemia)
04/2022 - 04/2002
17Atherosclerosis
01/2022 - 01/2005
16Hypertrophy
01/2022 - 01/2002
15Colitis
10/2022 - 12/2010
15Pancreatitis
05/2022 - 05/2002
15Necrosis
02/2022 - 11/2002
15COVID-19
01/2022 - 01/2020
14Neuralgia (Stump Neuralgia)
01/2022 - 01/2003
13Glioma (Gliomas)
11/2022 - 10/2007
13Cicatrix (Scar)
10/2022 - 03/2010
13Ischemic Stroke
08/2022 - 10/2013

Drug/Important Bio-Agent (IBA)

186Proteins (Proteins, Gene)FDA Link
10/2022 - 07/2002
91Biomarkers (Surrogate Marker)IBA
11/2022 - 10/2003
71Pharmaceutical PreparationsIBA
11/2022 - 09/2005
66CytokinesIBA
01/2022 - 05/2002
58Epoxide HydrolasesIBA
01/2022 - 01/2009
55Biological ProductsIBA
11/2022 - 01/2000
54Messenger RNA (mRNA)IBA
03/2022 - 07/2002
46MicroRNAs (MicroRNA)IBA
11/2022 - 01/2010
44LipidsIBA
02/2022 - 12/2002
37EnzymesIBA
10/2022 - 02/2009
32Peptides (Polypeptides)IBA
04/2022 - 12/2002
30Therapeutic UsesIBA
11/2021 - 07/2003
29AcidsIBA
03/2022 - 05/2007
28Glucose (Dextrose)FDA LinkGeneric
09/2022 - 08/2002
28Fatty Acids (Saturated Fatty Acids)IBA
11/2021 - 12/2009
26Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
08/2021 - 04/2003
25Long Noncoding RNAIBA
07/2022 - 05/2012
25CollagenIBA
03/2021 - 02/2002
22Interleukin-6 (Interleukin 6)IBA
01/2022 - 02/2003
22SodiumIBA
12/2021 - 03/2003
21RNA (Ribonucleic Acid)IBA
11/2022 - 09/2004
21Small Interfering RNA (siRNA)IBA
01/2022 - 08/2009
20Androgen Receptors (Androgen Receptor)IBA
07/2022 - 04/2006
19DNA (Deoxyribonucleic Acid)IBA
01/2022 - 09/2002
19Arginine Vasopressin (Argipressin)IBA
01/2019 - 01/2006
18Anti-Bacterial Agents (Antibiotics)IBA
05/2022 - 09/2005
18salicylhydroxamic acid (SHAM)IBA
04/2022 - 01/2003
18Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 05/2002
18Caspase 3 (Caspase-3)IBA
01/2022 - 02/2003
18Reactive Oxygen Species (Oxygen Radicals)IBA
12/2021 - 06/2003
18Indicators and Reagents (Reagents)IBA
01/2021 - 02/2004
17AntioxidantsIBA
01/2022 - 11/2004
17AndrogensIBA
11/2021 - 08/2002
17LigandsIBA
04/2021 - 04/2006
17Toll-Like Receptor 4IBA
01/2021 - 01/2008
16Transcription Factors (Transcription Factor)IBA
06/2022 - 09/2003
16InterferonsIBA
10/2021 - 04/2007
16Hydrogen Sulfide (Sulfide, Hydrogen)IBA
01/2021 - 01/2015
15AldosteroneIBA
01/2022 - 10/2010
15CalciumIBA
01/2022 - 03/2003
15Phosphotransferases (Kinase)IBA
01/2019 - 01/2003
14Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
05/2022 - 12/2010
14CateninsIBA
01/2022 - 12/2010
14Insulin (Novolin)FDA Link
01/2022 - 08/2007
14Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
01/2021 - 04/2012
14Epoxy Compounds (Epoxides)IBA
01/2021 - 01/2013

Therapy/Procedure

225Therapeutics
02/2022 - 08/2002
45Drug Therapy (Chemotherapy)
05/2022 - 08/2002
34Radiotherapy
06/2022 - 01/2003
29Moxibustion
06/2022 - 02/2008
15Aftercare (After-Treatment)
01/2022 - 11/2006
15Transplantation
10/2021 - 04/2006
14Lasers (Laser)
01/2022 - 05/2007
14Length of Stay
01/2022 - 10/2010